BioSpace News Archive

Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review updates and results for its fiscal year ended on Sept. 30, 2022, on Dec. 20, 2022, beginning at 1:30 pm PT.

AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTC: AVMR), a medical robotics software and artificial intelligence company announced that it is continuing to progress to consummation of its acquisition by merger of CardioVentures, Inc. (“CardioVentures”), as previously reported in its Current Report on Form 8-K filed with the SEC on November 7, 2022.

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) (“ScreenPro” or the “Company”) is pleased to report that further to the news release of November 10, 2022, the Company has closed a non-brokered private placement financing of units of the Company (“Units”) at a price of $0.05 per Unit (the “Private Placement”).

Miromatrix Medical Inc. (NASDAQ: MIRO) today announced that it was informed via e-mail from the U.S. Food and Drug Administration (FDA) that the miroliverELAPtm Investigational New Drug (IND) application for the treatment of acute liver failure has been placed on clinical hold.

Axcella Therapeutics, a biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator compositions, announces a repositioning of its strategy to focus on Long COVID and realize value from its platform and current programs.

The ASUCOV trial assesses efficacy and safety of asunercept on top of standard of care Over 600 patients to be enrolled at 50 trial sites in Europe, India, and South Africa Trial funded by the German Federal Government and dievini Hopp BioTech

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received clearance from the U.S. Food & Drug Administration (FDA) to market the TruLift Lateral Expandable Spacer System and Lateral Plate System.

The Leukemia & Lymphoma Society recognized and celebrated the outstanding contributions of six LLS-funded scientific investigators for their achievements in helping drive forward its lifesaving mission.

Solve Therapeutics, Inc. (SolveTx), an oncology-focused biopharmaceutical company, announced today its mission to develop novel antibody-based therapies targeting tumor-specific antigens.

Pasithea Therapeutics Corp., a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system disorders, announced the final results of the Special Meeting of Stockholders held on December 9, 2022.